{"text": ["Novartis", "Reports", "Data", "on", "Asthma", "Drug,", "Update", "from", "Annual", "Meet"], "created_at": "2019-05-23 22:10:53"}
{"text": ["Novartis", "Reports", "Data", "on", "Asthma", "Drug,", "Update", "from", "Annual", "Meet"], "created_at": "2019-05-23 22:10:53"}
{"text": ["Novartis", "Reports", "Data", "on", "Asthma", "Drug,", "Update", "from", "Annual", "Meet"], "created_at": "2019-05-23 19:46:07"}
{"text": ["Tilray", "Stock", "Still", "Hasn\u2019t", "Bottomed"], "created_at": "2019-05-23 18:17:30"}
{"text": ["Alphabet", "to", "Aid", "Pharma", "Giants", "Enhance", "Clinical", "Trial", "Process"], "created_at": "2019-05-23 16:16:11"}
{"text": ["Alphabet", "to", "Aid", "Pharma", "Giants", "Enhance", "Clinical", "Trial", "Process"], "created_at": "2019-05-23 16:16:11"}
{"text": ["Novartis", "CEO", "says", "data", "quality,", "lagging", "innovation", "crimp", "China", "M&A"], "created_at": "2019-05-23 15:58:01"}
{"text": ["(Re)Focusing", "Big", "Pharma:", "Novartis", "CEO", "Vasant", "Narasimhan", "with", "Jim", "Cramer", "at", "Healthy", "Returns"], "created_at": "2019-05-23 15:42:12"}
{"text": ["After", "IFM", "buy,", "Novartis", "looks", "to", "more", "early", "stage", "biotech", "M&A"], "created_at": "2019-05-23 15:02:08"}
{"text": ["Novartis", "CEO", "sees", "China", "M&A", "hampered", "by", "data,", "regulatory", "standards"], "created_at": "2019-05-23 14:48:58"}
{"text": ["Alphabet", "to", "Aid", "Pharma", "Giants", "Enhance", "Clinical", "Trial", "Process"], "created_at": "2019-05-23 14:03:02"}
{"text": ["Novartis", "CEO", "sees", "chance", "to", "accelerate", "profit", "margin", "target"], "created_at": "2019-05-23 13:22:30"}
{"text": ["Novartis", "has", "25", "blockbusters", "in", "the", "pipeline:", "CEO"], "created_at": "2019-05-23 05:37:43"}
{"text": ["Novartis", "has", "25", "blockbusters", "in", "the", "pipeline:", "CEO"], "created_at": "2019-05-23 05:37:43"}
